CStone Pharmaceuticals racks up $150 mln

Chinese biopharmaceutical company CStone Pharmaceuticals Co Ltd has raised $150 million in funding. The investors were Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures.

5 July 2016•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail